In this sample of moderately to severely depressed outpatients, nefazodone therapy proved superior to placebo. Nefazodone therapy was also associated with fewer dropouts from adverse effects than was imipramine. In view of these efficacy findings as well as the promising side effect and safety profile of nefazodone, further research is warranted to evaluate its therapeutic potential in the treatment of depressive illness.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
nefazodone therapy
8
comparison nefazodone
4
nefazodone imipramine
4
imipramine placebo
4
placebo patients
4
patients moderate
4
moderate severe
4
severe depression
4
depression sample
4
sample moderately
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!